Original Article |
|
Academic editor: Georg Stingl
© 2025 Yi Pan, Mathias Hochgerner, Natalie Bordag, Markus Absenger-Novak, Herbert Strobl, Thomas Bieber, Peter Wolf.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC 4.0), which permits to copy and distribute the article for non-commercial purposes, provided that the article is not altered or modified and the original author and source are credited.
Citation:
Pan Y, Hochgerner M, Bordag N, Absenger-Novak M, Strobl H, Bieber T, Wolf P (2025) Live but not heat-killed Staphylococcus epidermidis elicit an anti-inflammatory phenotype in human embryonic Langerhans cells. SKINdeep 1: e142637. https://doi.org/10.1553/skindeep.2025.142637
|
Background: In atopic dermatitis (AD), the skin is colonized by high levels of Staphylococcus aureus (SA), while levels of the commensal Staphylococcus epidermidis (SE) are reduced. Levels of SA correlate with the severity of the disease, while transplantation of SE into the skin can ameliorate AD.
Objectives: It is hypothesized that the underlying mechanism is supported by Langerhans cells (LCs) which sense a shift in the microbiome and then either continue to perpetuate the disease (with SA) or to act as anti-inflammatory agents, ameliorating the inflammation (with SE). However, many different experimental protocols generating very different results have made the literature on this topic complex and hard to understand.
Methods: In this study, we specifically tested human, embryonic stem cell-derived LCs and measured their reactions to SA and SE. We directly compared co-cultures exposed to living SA and SE and to heat-killed bacteria. We analyzed the gene expression of the LCs with qPCR and flow cytometry, the secreted cytokines via ELISA, and their downstream effect on T cells.
Results: Our data show that exposure to living SA causes LCs to mature; in turn, this activates a T-cell response of cytokine secretions resembling the inflammatory phenotype observed in AD patients. Meanwhile, SE-primed LCs do not activate T cells, but instead act as anti-inflammatory agents by secreting high levels of IL-10. Importantly, this difference can only be observed in living bacteria. LCs react to heat-killed SE as pro-inflammatory agents, as they do to SA (albeit slightly weaker).
Conclusions: Using living bacteria is absolutely crucial when performing experiments to reflect the in vivo situation. Our results expand on the work of others and contribute to the ongoing investigation of interactions of the skin and its microbiome.
Why was the study undertaken?
Numerous studies have observed that SE not only correlates with less severe AD, but can ameliorate the disease. This study was undertaken to further investigate the immunological mechanisms related to this effect.
What does this study add?
Our data shows that SE modifies T-cell reactions via LCs. Importantly, only living SE has this anti-inflammatory effect; heat-killed SE instead has a pro-inflammatory effect similar to that of S. aureus.
What are the implications of this study for the understanding of skin physiology and pathology and/or disease management?
The skin microbiome plays a key role in AD, but at the heart of AD pathophysiology are T cells. We present further evidence that the missing link between the microbiome and the T cells is in fact the LCs.
List of abbreviations: AD: Atopic dermatitis; APC: Antigen-presenting cell; DC: Dendritic cell; LC: Langerhans cell; mo-LC: Monocyte-derived Langerhans cell; LN: Lymph nodes; PBMCs: Peripheral blood mononuclear cells; SA: Staphylococcus aureus; SE: Staphylococcus epidermidis.
Langerhans cell, atopic dermatitis, skin microbiome, immunology, Staphylococcus aureus, Staphylococcus epidermidis
Langerhans cells are myeloid immune cells that display dendritic morphology and form a tight network in the epidermis [
LC dendrites extend through tight junctions, also allowing them to take up antigens on the surface of the skin, which have not penetrated into the body [
Healthy human skin is colonized by a wide variety of microbes. The skin and the microbiome constantly interact, influencing each other [
The microbiome is of special interest in chronic skin diseases. Many skin diseases are associated with changes in the microbiome. One such disease is atopic dermatitis [
LCs are key cells in AD; while their exact function remains incompletely understood, studies have shown that LCs in AD patients are highly activated and pro-inflammatory [
Currently, scientists hypothesize that LCs in the epidermis sense SE, react by inducing anti-inflammatory programs and then shape the downstream immune reaction accordingly. Thus, not only is the inflammation perpetuated by SA in AD, but the important anti-inflammatory signal from SE is also lost [
Much research has already been performed in this field. However, information in the literature is far from consistent. Some studies have used human cells, while others have used mouse cells. While the two seem very similar, murine and human skin are actually quite different [
Many studies use bone marrow-derived, LC-like DCs or work with monocyte-derived LCs (mo-LCs), which are both quite different from real, embryonic LCs. For example, mo-LCs but not real LCs have been shown to be drivers of AD [
On the other hand, some studies have used living bacteria (or the cell culture supernatant from these), while others have used killed bacteria (produced with different protocols) or only bacterial components. Importantly, one study has demonstrated that the method of killing bacteria strongly changes their antigenicity and the reaction of immune cells to them [
In this study, we compared the reactions of human embryonically derived LCs to SA and to SE. We compared the effects of exposing both heat-killed and living bacteria to LC and analyzed LC gene expression, marker expression and secreted cytokines. The study results help to clarify some of the confusion in the literature.
Cord blood was collected after healthy full/term deliveries, and peripheral blood mononuclear cells (PBMCs) were isolated by performing density gradient centrifugation with Ficoll® Paque Premium media. Afterwards, CD34+ stem cells were isolated by applying magnetic sorting with a Miltenyi Biotech CD34+ micro bead kit according to the manufacturer’s instructions. The purity of each batch of enriched cells was confirmed with flow cytometry. Only isolates with a purity of > 95% were used for experiments. CD34+ stem cells were stored in liquid nitrogen until use. Informed consent forms were obtained from all patients as required by the Declaration of Helsinki. Ethics approval was obtained from the ethics committee of the University of Bonn and the Medical University of Graz Institutional Review Board (26-520).
Thawed CD34+ hematopoietic stem cells were differentiated into LCs over 8 days in cell culture. We used RMPI 1640 with GlutaMAXTM, 50 µM 2-mercaptoethanol, 10% FBS and 1% penicillin-streptomycin as a differentiation medium with GM-CSF (300 IU/ml), mIgE (1 µg/ml), FLT3L (10 ng/ml), SCF (10 ng/ml), TGF-β (0.5 ng/ml) and TNF-α (20 U/ml). After 8 days of differentiation, LCs were collected and enriched with a Miltenyi Biotech CD207+ micro bead kit according to the manufacturer’s instructions. The purity of the generated CD207+ cells was confirmed with flow cytometry. In further experiments, only isolates with a purity of > 90% were used.
Antibodies used for flow cytometry are listed in Table
| Antibody | Source | Clone | Identifier # |
|---|---|---|---|
| Biotin anti-human CD281 (TLR1) Antibody | Biolegend | TLR1.136 | 334504 |
| Brilliant Violet 605™ Mouse IgG1 | Biolegend | MOPC-21 | 400161 |
| CCR5 APC | Miltenyi Biotec | REA245 | 130-123-057 |
| CCR6 PE | Miltenyi Biotec | REA190 | 130-120-458 |
| CCR7 PE | Miltenyi Biotec | REA546 | 130-119-583 |
| CD11b Percpvio700 | Miltenyi Biotec | REA713 | 130-110-557 |
| CD11c Viobright515 | Miltenyi Biotec | REA618 | 130-127-207 |
| CD14 APC | Miltenyi Biotec | TÜK4 | 130-113-705 |
| CD14 Percpvio700 | Miltenyi Biotec | REA599 | 130-110-523 |
| CD1a RD1 | Beckman Coulter | SCFI19Thy1A8 | 6603185 |
| CD1a VioBlue | Miltenyi Biotec | REA736 | 130-111-875 |
| CD1b PEvio770 | Miltenyi Biotec | SN13 | 130-101-578 |
| CD1c PEvio615 | Miltenyi Biotec | REA618 | 130-126-883 |
| CD206 Percpvio700 | Miltenyi Biotec | DCN228 | 130-104-129 |
| CD207 | Beckman Coulter | DCGM4 | PN IM3449 |
| CD207 APC-Vio770 | Miltenyi Biotec | REA770 | 130-112-214 |
| CD209 Percpvio700 | Miltenyi Biotec | REA617 | 130-109-593 |
| CD324 PEvio615 | Miltenyi Biotec | REA811 | 130-125-732 |
| CD34 PE | Becton Dickinson | 581 (RUO) | 555822 |
| CD36 PE | Miltenyi Biotec | REA760 | 130-110-740 |
| CD40 PEvio770 | Miltenyi Biotec | REA733 | 130-110-948 |
| CD80 PE | Miltenyi Biotec | REA661 | 130-123-253 |
| CD83 | Santa Cruz Biotechnology | HB15a | sc-19677 |
| CD83 APC | Miltenyi Biotec | REA714 | 130-110-504 |
| CD86 Viobright515 | Miltenyi Biotec | REA968 | 130-116-165 |
| CX3CR1 APC | Miltenyi Biotec | REA385 | 130-122-912 |
| CXCR1 PEvio770 | Miltenyi Biotec | REA958 | 130-115-881 |
| FceR1a | eBioscience | AER-37 | 16-5899-025 |
| FceRIa FITC | Miltenyi Biotec | REA758 | 130-110-726 |
| Gam FITC | Jackson ImmunoResearch | Polyclonal | 115-095-003 |
| HLA-DR PEvio615 | Miltenyi Biotec | REA805 | 130-111-797 |
| IgG1 PE | Becton Dickinson | X40 | 340761 |
| IgG1 RD1 | Beckman Coulter | 2T8-2F5 | 6602884 |
| IgG2a APC | Miltenyi Biotec | S43.10 | 130-113-831 |
| IgG2b | Sigma-Aldrich | MOPC-141 | M5534 |
| mouse IgG1κ Percpvio700 | Miltenyi Biotec | IS5-21F5 | 130-113-776 |
| mouse IgG1κ PEvio770 | Miltenyi Biotec | IS5-21F5 | 130-113-764 |
| Recombinant human IgG1 APC | Miltenyi Biotec | REA293 | 130-113-446 |
| Recombinant human IgG1 APC-Vio770 | Miltenyi Biotec | REA293 | 130-113-447 |
| Recombinant human IgG1 FITC | Miltenyi Biotec | REA293 | 130-113-449 |
| Recombinant human IgG1 PE | Miltenyi Biotec | REA293 | 130-113-450 |
| Recombinant human IgG1 Percpvio700 | Miltenyi Biotec | REA293 | 130-113-453 |
| Recombinant human IgG1 PEvio615 | Miltenyi Biotec | REA293 | 130-113-451 |
| Recombinant human IgG1 PEvio770 | Miltenyi Biotec | REA293 | 130-113-452 |
| Recombinant human IgG1 VioBlue | Miltenyi Biotec | REA293 | 130-113-454 |
| Recombinant human IgG1 Viobright515 | Miltenyi Biotec | REA293 | 130-113-457 |
| TLR2 | Imgenex | 1030A5.138 | MAB0066 |
| TLR2 PEvio615 | Miltenyi Biotec | REA109 | 130-107-462 |
| TLR6 PE-Vio770 | Miltenyi Biotec | REA382 | 130-106-590 |
| Trop1 FITC | Miltenyi Biotec | REA764 | 130-110-998 |
| Trop2 APC | Miltenyi Biotec | REA916 | 130-115-056 |
RNA was isolated from harvested cells by using the TRIzol® reagent and following the manufacturer’s protocol. The RNA concentration and purity were measured with a NanoDrop™ spectrophotometer (Thermo Fisher Scientific, MA, USA). The RNA was then transcribed to cDNA by using the SuperScript™ reverse transcriptase.
qRT-PCR was performed with the SYBR® Green Supermix with ROXTM according to the manufacturer’s instructions. The primers used are listed in Table
| Gene | Forward sequence | Reverse sequence |
|---|---|---|
| ACTB | AGCGCGGCTACAGCTTCA | TCCTTAATGTCACGCACGATTT |
| CCL13 | GTGCCTGCTGCTCATGACA | TGCATCTGGCTGAGCAAGTC |
| CCL17 | GAAGACGTGGTACCAGACATCTGA | CCCTGCACAGTTACAAAAACGA |
| CCL22 | CGGCGCCAACATGGAA | CAGACGGTAACGGACGTAATCA |
| CCR6 | CCATTCTGGGCAGTGAGTCA | GCACGTGGCATTGCTGAA |
| CCR7 | GCTGCGTCAACCCTTTCTTG | AAGAGATCGTTGCGGAACTTG |
| CD83 | GCCTCGAAAACCATCACATGA | GGTGGCCATGGAGAAGCA |
| Elf.1 | TGCCCCAGTCACCCATGT | ACCCGGTGAGTCTGCATATT |
| FceRIa | GGCAGCTGGACTATGAGTCTGA | CTTCTCACGCGGAGCTTTTATT |
| FceRIg | GATGCCATCCTGTTTCTGTATGG | CACTTGGATCTTCAGTCGACAGTAG |
| HMGB1 | GATCCTAAGAAGCCGAGAGGC | CTTATGCTCCTCCCGACAAGT |
| HMGB2 | CCCGGACTCTTCCGTCAATT | TCTTCCATCTCTCCGAACACTTC |
| IL-13Ra1 | AAGCGCAATTCCACACTCTACA | TGCACCTGCGACGATGACT |
| IL-2Rg | TGTCTAAGGGACTGGCTGAGAGT | TGACGAGGCAGAGTCGTTCA |
| IL-4Ra | CCTGGAGCAACCCGTATCC | CAAATGTTGACTGCATAGGTGAGAT |
| Jak1 | CGAGATCCCCTTGAAAGACAAG | TGCACCGGCTTTCATAGAATC |
| Jak2 | TGCTCCAGAATCACTGACAGAGA | ACCACTCCAAAGCTCCAAACA |
| Jak3 | TGCCATCAACAAGCTCAAGACT | TGCCATCAACAAGCTCAAGACT |
| MY88 | TCACTGTCTGCGACTACACCAA | GGCAAGGCGAGTCCAGAAC |
| PU.1 | GGAGAGCCATAGCGACCATT | GGAGCTCCGTGAAGTTGTTC |
| SP1 | GGACTACCTGGAGTGATGCCTAA | CCCATCAACGGTCTGGAACT |
| TLR1 | TGTGCTGCCAATTGCTCATT | TTTTCCCCATAAGTCTCTCCTAAGAC |
| TLR2 | CCAAGGAAGAATCCTCCAATCA | GCTGCCCTTGCAGATACCA |
| TLR4 | CCTCGGCGGCAACTTCATAA | AGAGCGGATCTGGTTGTACTG |
| TLR6 | GGGACTCAGCATGGTAGAAGGTA | CTCCTGTTACTCTGCAAGCTTTCA |
| Tyk2 | TTCTCTCTGCGTCGCTGTTG | CCGCATGATGATGAGATTGG |
| YY.1 | GTTCAGGGATAACTCGGCCA | TTCTGCACAGACGTGGACTC |
LCs were stained with 5 μM CellTracker™ Blue CMHC Dye in clear, serum-free media. Live SA from 1 ml stock (OD600 = 0.5) was stained with 5 μg/ml SA polyclonal antibody and 5 μg/ml goat anti-rabbit IgG secondary antibody Alexa Fluor 546. Live SE from 1 ml stock (OD600 = 0.5) was stained with 5 μg/ml SE monoclonal antibody and 5 μg/ml goat anti-mouse IgG secondary antibody Alexa Fluor 488. Then, 100 μl of stained live bacteria suspension were added to 5 ml of LCs. Cells were imaged with a Nikon Eclipse Ti2-E inverted microscope, taking one image every 10 min. NIS-Elements C software was used for the image analysis. The antibodies used for live imaging are listed in Table
| Antibody | Source | Clone | Identifier # |
|---|---|---|---|
| Goat anti-Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 488 | Invitrogen | Polyclonal | A-11001 |
| Goat anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 546 | Invitrogen | Polyclonal | A-11035 |
| Staphylococcus aureus Polyclonal Antibody | Invitrogen | Polyclonal | PA1-7246 |
| Staphylococcus epidermidis Monoclonal Antibody | Invitrogen | 17-5 | MA1-35788 |
SA (DSM 20372) and SE (DSM 1798) cultures were purchased from the Leibniz Institute DSMZ (German Collection of Microorganisms and Cell Cultures GmbH) in Braunschweig Science Campus, Braunschweig-Süd, Germany. bacteria were grown on tryptic soy agar, and colonies were then inoculated into tryptic soy broth (TSB). bacteria were grown to an OD600 of 0.6, then harvested. For experiments with inactivated bacteria, these were fixed in formalin (1.5%, 1 h, RT) and then heat-inactivated (80 °C, 10 min). For experiments with live bacteria, the overnight culture was used to inoculate fresh RT TSB at a dilution of 1:200. bacteria used for infections were harvested at an OD600 of 0.5. Serial dilutions of the inoculum were plated onto tryptic soy agar to quantify the titre (viable bacteria).
Cell culture supernatants were collected from the experiments and sterile filtered. Cytokines were measured with LEGENDplex™ cytokine bead assays according to the manufacturer’s instructions. The following kits were used: LEGENDplex™ Human Proinflammatory Chemokine Panel 1 (13-plex), LEGENDplex™ Human Inflammation Panel 1 (13-plex) and LEGENDplex™ Human Th Cytokine Panel (12-plex).
Peripheral blood was collected from healthy volunteers. PBMCs were isolated with density gradient centrifugation as for cord blood. CD4+ T cells were isolated by performing magnetic sorting with a Miltenyi Biotech CD4+ micro bead kit (130-096-533) according to the manufacturer’s instructions. The purity of the enriched cells was assessed with flow cytometry. In further experiments, only isolations with a cell purity of ≥ 95% were used. Isolated CD4+ T cells were stored in liquid nitrogen until use.
Cord blood-derived LCs were primed with live SA or live SE cultures for 1 hour, then harvested, thoroughly washed and counted. 1×105 viable LCs were co-cultured with 5×105 T cells (LC:TC = 1:5) in 96-well round bottom tissue culture plates in RMPI 1640 10% FBS, 5% penicillin-streptomycin. Cells were harvested after five days and analyzed with flow cytometry. The cell culture medium was analyzed by performing cytokine ELISA. All experiments were performed in duplicate.
Gene expression (qRT-PCR) and cytokine measurements (ELISA) were visualized and analyzed with R [
All other statistical analyses were performed using GraphPad Prism V8 software (GraphPad Software). Differences between the two groups were calculated with a two-tailed Student’s t-test. Multiple groups were compared by applying a one-way analysis of variance (ANOVA), corrected with Tukey’s multiple comparison test.
In mice and humans, different types of cells have been called “LCs” or “LC-like cells”. However, there are significant differences between real LCs (embryonically derived and self-renewing), mo-LCs (monocyte-derived) and mucosal LCs (bone marrow-derived). In our study, we generated LCs from human cord-blood-derived CD34+ embryonic stem cells. We used a protocol previously developed by our group to generate LCs matching the phenotype found in the skin of AD patients [
First, we exposed our LCs to heat-killed SA and SE overnight and analyzed LC activation with qPCR and flow cytometry (Fig.
Next, we analyzed the expression of key transcription factors, receptors and cytokines with qPCR (Fig.
Exposure to heat-killed SA and SE causes LCs to activate and mature: A) CD34+ stem cell-derived LCs were exposed for 24 h to heat-killed SA or SE; LCs were harvested and analyzed with qPCR; B) violin plots depict the distribution of cytokine cDNA levels. Each dot represents an individual biological replicate (n = 6). Significant differences between groups were determined by linear mixed-effects models with generalized least squares, followed by the application of a Benjamini-Hochberg correction for multiple comparisons. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001; C) flow cytometry; D) expression levels were normalized to actin. One-way ANOVA, dots represent biological replicates, n = 7–9.
Next, we collected the supernatant of our cell cultures and analyzed the secreted cytokines by performing multiplex ELISA (Fig.
Exposure to heat-killed SA and SE causes LCs to secrete pro-inflammatory cytokines. LCs were stimulated with heat-killed SA or SE for 24 h; then cell culture supernatants were collected and secreted cytokines were analyzed via multiplex ELISA: A) heat-map and B) violin plots depict the distribution of secreted cytokine levels. Each dot represents an individual biological replicate (n = 6). Significant differences between groups were determined by linear mixed-effects models with generalized least squares, followed by the application of a Benjamini-Hochberg correction for multiple comparisons. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001, n = 6.
In vivo observations correlate high levels of SA with increased inflammation and high levels of SE with reduced inflammation. Contrary to this observation, our first set of experiments showed that LCs react the same way to SA and SE. However, these experiments were performed with heat-killed cells.
In order to better reflect the in vivo situation, we next co-cultured LCs with living SA or SE. We observed the LCs by performing live cell imaging for 4 h. Additionally, LCs were collected after 1 h for flow cytometry analysis.
LCs co-cultured with SA displayed fast, mesenchymal migration. They were also observed to actively engulf SA. LCs co-cultured with SE displayed slow, amoeboid movement and did not engulf bacteria (Fig.
SA-LCs were strongly activated, as shown by the upregulation of HLA-DR, CD80, CD86 and CCR7. Interestingly, SE-LCs did not display an upregulation of any of these markers. LCs definitely reacted to exposure to SE, as evidenced by the upregulation of CD1b and CCR5 (also upregulated in SA to comparable levels). However, these cells did not mature (Fig.
Exposure to live SA activates LCs, while exposure to live SE does not. LCs were co-cultured with live SA or SE: A) live microscopy of LCs co-cultured with SA (red); B) live microscopy of LCs co-cultured with live SE (green); C) viability of LCs co-cultured with live bacteria; D) flow cytometry analysis of LC activation after 1 h. One-way ANOVA, dots represent biological replicates, n = 4.
We next collected the supernatants from the co-cultures of LCs and living bacteria and analyzed the cytokines secreted into this supernatant after 1 h, 2 h and 3 h of exposure, respectively, with multiplex ELISA. Already after 1 h of co-culture, SA-LCs and SE-LCs show highly distinct cytokine profiles. These differences are only stronger at later timepoints (Fig.
Specifically, SA-LCs express more IFN-α2, IL-18, IL-1β, IP-10 and (at early timepoints only) TNFα and CCL5. In contrast, SE-LCs express (at later timepoints) more IL-10, IL-6, IL-8, CCL2 and CCL4. Cytokines that were identified but where amounts did not significantly change are shown in Suppl. material
Thus, LCs secrete cytokines upon exposure to both SA and SE, but the secretory profiles of these LCs are very different. Of note, LC death in the SA culture impacts the secretory profile. The observations of early (1 h) increases in cytokine levels in these cultures may be partly due to their release upon LC death. However, in AD patients where SA infiltrates the epidermis and releases exotoxins there, LC death may also be expected.
LCs co-cultured with live SA or SE show different cytokine profiles. LCs were co-cultured with living SA or SE for 1, 2 or 3 h, then supernatant was collected and analyzed with multiplex ELISA. A) heatmap and B) violin plots of secreted cytokines. One-way ANOVA, dots represent biological replicates, n = 4.
Next, we investigated the downstream effect of SA-/SE-LC co-culturing. We exposed LCs to live SA or SE for 1 h, then isolated and washed the LCs. We then co-cultured them together with T cells for five days. The flow cytometry analyses show that exposure to SA-primed LCs induced the activation and proliferation of T cells. T cells co-cultured with SE-primed LCs did not proliferate. They did however still upregulate CD25, indicating that some form of activation occurred (Fig.
The multiplex ELISA of the cell culture supernatant shows that SA-primed cultures contained secretions of high levels of the interleukins IL-5, IL-6, IL-9 and IL-22. SE-primed cultures show no significant upregulation of these cytokines compared to un-primed controls. SE-priming of LCs, however, induced very high secretions of IL-10, which was not found in SA-primed cultures (Fig.
Of note, patients suffering from AD display increased serum levels of IL-5 and IL-6 [
SA-primed LCs cause T-cell proliferation and secretion of cytokines. LCs were exposed to SA or SE for 1 h, then washed and co-cultured with T cells for 5 d. A, B) flow cytometry measurements of activation and proliferation of T cells; C) multiplex ELISA measurements of secreted cytokines. One-way ANOVA, dots represent biological replicates, n = 4.
Due to their position upstream of T cells, LCs may be important therapeutic targets for the treatment of many skin diseases. Especially AD is a highly heterogenous disease, manifesting Th1, Th2, Th17 or Th22 biases. SA is associated with the severity of AD, but different sub-strains of SA are additionally associated with more severe or specific sub-forms of the disease. Conversely, transplanting SE onto the skin of patients suffering from AD has been shown to ameliorate their symptoms [
Understanding the underlying mechanisms of this effect would allow dermatologists to control the disease more efficiently and offer more effective treatments. Targeting the LCs may offer an effective treatment strategy as an alternative to live-bacteria transplantation; however, this topic is complex and still incompletely understood.
In this study, we show that embryonically derived human LCs react very differently to SA than to SE. Specifically, exposure to SA leads to the activation and maturation of LCs and, further downstream, to the initiation of an inflammatory T-cell response.
In contrast, exposure to SE does not induce LC maturation, but definitely has an effect beyond merely not being pro-inflammatory. Our study findings demonstrate that SE-primed LCs alter their receptor expression and cytokine secretion patterns and influence T cells differently. However, the secretome of these LCs differs from that of SA-primed LCs. T cells co-cultured with SE-primed LCs show activation, but not proliferation. Importantly, SE-LC-primed T cells secrete high levels of IL-10. These findings indicate that SE-LCs may push T cells towards an anti-inflammatory/tolerogenic phenotype, but more research on T cells is needed to clarify this point.
Importantly, these results are only true for LCs co-cultured with living bacteria. While we could detect some differences in LC response when they were exposed to heat-killed SA and SE, these differences were only quantitative. In essence, the LCs show the same type of reaction to heat-killed SA as to SE. Therefore, heat-killing the bacteria seems to destroy whatever anti-inflammatory properties SE may have.
Our results match observations made in clinical settings and also reported in the literature. Laborel-Prenéron et al. showed that the secretome of live SA induces maturation of mo-DCs, but exposure to SE induces an anti-inflammatory phenotype [
LCs express a wide variety of pattern-recognition-receptors (PRR), but their PRR expression is very different from that of conventional DCs or macrophages. For this reason, LCs may react differently when exposed to the same antigen [
We hope that our work can help guide further research on this topic. While our findings match those previously obtained in studies on other types of APCs, we again stress the huge impact of heat-killing the bacteria. This denatures the proteins, prohibits the bacteria from producing secreted factors, and exposes molecules which would otherwise be hidden inside the bacteria from the host’s immune system. Thus, heat-killing of bacteria not only destroys antigens, but may also produce/expose neo-antigens which would otherwise not exist in the in vivo situation.
One possible alternative to heat killing may be inactivation with radiation. In a direct comparison, several strains of bacteria elicited significantly stronger immune reactions when heat-killed than when radiation-inactivated [
Parts of the laboratory work of this research were conducted by Yi Pan when she was a PhD student at the University Hospital of Bonn, Bonn, Germany. We sincerely thank Christina Passegger for her excellent technical assistance.
The authors have declared that no competing interests exist.
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University Bonn (Nr. 204/09) and the Medical University of Graz Institutional Review Board (26-520).
The authors declared that no clinical trials were used in the present study.
The authors declared that no experiments on humans or human tissues were performed for the present study.
The authors declared that no informed consent was obtained from the humans, donors or donors’ representatives participating in the study.
The authors declared that no experiments on animals were performed for the present study.
The authors declared that no commercially available immortalised human and animal cell lines were used in the present study.
PW was supported by the Austrian Science Fund (FWF - W1241). YP was supported by the China Scholarship Council and received research support from the company Shanghai Biocelline Enterprise Co. Ltd, China. The project was supported by the Christine Kühne Center for Allergy Research and Education, Davos, Switzerland.
YP: Conceptualization; Funding acquisition; Material preparation; Planning and performing the experiments; Data collection and analysis; Writing original draft. MH: Planning and performing the experiments; Data analysis; Writing and editing. NB: Data analysis; Software; Visualization. MA: Live imaging. HS: Collect and prepare human stem cells. TB: Conceptualization; Funding acquisition; Supervision; Review and editing. PW: Conceptualization; Funding acquisition; Supervision; Review and editing.
Yi Pan https://orcid.org/0000-0001-6723-1370
Mathias Hochgerner https://orcid.org/0000-0003-4987-4393
Natalie Bordag https://orcid.org/0000-0002-9505-6271
Herbert Strobl https://orcid.org/0000-0002-8070-4977
Thomas Bieber https://orcid.org/0000-0002-8800-3817
Peter Wolf https://orcid.org/0000-0001-7777-9444
All of the data that support the findings of this study are available in the main text or Supplementary Information.
Supplementary figures
Data type: pdf
Explanation note: figure S1. Generation of LCs from human cord blood CD34+ stem cells. A) CD34+ stem cells were isolated from human cord blood from healthy deliveries and differentiated to LCs as shown above. B) LCs were enriched and qualitycontrolled via flow cytometry. figure S2. Heat-killed S.A. and S.E. both cause LCs to activate and mature. LCs were exposed to S.A. or S.E. for 24h, then gene expression was analyzed via qPCR. Violin plots depict the distribution of cytokine cDNA levels, normalized to actin and log10-transformed. Each dot represents an individual biological replicate (n=6). Significant differences between groups were determined by linear mixed-effects models with generalized least squares, followed by Benjamini-Hochberg correction for multiple comparisons. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001. figure S3. Living SA leads to LC activation, live SE does not. LCs were co-cultured with living SA or SE; Flow cytometry analysis of LC activation after 1h. Grey: Isotype control. Blue: unstimulated LCs. Green: LCs stimulated with S.e. Red: LCs stimulated with S.a. Representative plots from one experiment of two; n=4 per group. figure S4. Tested, but non-significant cytokines (cytokine ELISA from cell culture supernatants). A) LCs were co-cultured with living SA or SE for 1, 2 or 3h (Ad Figure